Kastalia is Filter‘s deputy editor. She previously worked at half a dozen mainstream digital media outlets and does not recommend the drug war coverage at any of them. For a while she was a syringe program peer worker in NYC, where she did outreach hep C testing and navigated participants through treatment. She also writes with Jon Kirkpatrick.
Three years in the making, the legislative push to place xylazine under Schedule III of the federal Controlled Substances Act…
In Illinois, a bill to authorize an overdose prevention center (OPC) pilot is working its way through the House. HB…
Two years after its approval by the Food and Drug Administration, opioid-overdose reversal product Rezenopy is about to make its…
The Drug Enforcement Administration has temporarily placed bromazolam, an unregulated benzodiazepine, under Schedule I of the Controlled Substances Act. The…
For the first time in the decade that the Los Angeles County Department of Public Health has been tracking mortality…
The Food and Drug Administration is asking the public to weigh in on the merits of commercial drug-disposal products, for…
On March 5, the Centers for Disease Control and Prevention a published a National Vital Statistics Report on the drugs most…
A minor media frenzy has been forming around cychlorphine, a novel synthetic opioid described as the "next killer drug" taking…
On March 2, the Drug Enforcement Administration published a final rule permanently scheduling five benzodiazepines under the Controlled Substances Act.…
Oklahoma is considering a bill that would increase the state’s authority to intervene when people use unregulated drugs during pregnancy,…